JP2012516686A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012516686A5 JP2012516686A5 JP2011548377A JP2011548377A JP2012516686A5 JP 2012516686 A5 JP2012516686 A5 JP 2012516686A5 JP 2011548377 A JP2011548377 A JP 2011548377A JP 2011548377 A JP2011548377 A JP 2011548377A JP 2012516686 A5 JP2012516686 A5 JP 2012516686A5
- Authority
- JP
- Japan
- Prior art keywords
- cftr
- cell
- seq
- nucleic acid
- cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000004027 cell Anatomy 0.000 claims 47
- 150000007523 nucleic acids Chemical class 0.000 claims 15
- 108020004707 nucleic acids Proteins 0.000 claims 14
- 102000039446 nucleic acids Human genes 0.000 claims 14
- 229920001184 polypeptide Polymers 0.000 claims 11
- 102000004196 processed proteins & peptides Human genes 0.000 claims 11
- 108090000765 processed proteins & peptides Proteins 0.000 claims 11
- 125000003275 alpha amino acid group Chemical group 0.000 claims 6
- 238000004113 cell culture Methods 0.000 claims 6
- 150000001875 compounds Chemical class 0.000 claims 4
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 3
- 238000000034 method Methods 0.000 claims 3
- 239000002773 nucleotide Substances 0.000 claims 2
- 125000003729 nucleotide group Chemical group 0.000 claims 2
- 201000003883 Cystic fibrosis Diseases 0.000 claims 1
- 102000008394 Immunoglobulin Fragments Human genes 0.000 claims 1
- 108010021625 Immunoglobulin Fragments Proteins 0.000 claims 1
- 241000124008 Mammalia Species 0.000 claims 1
- 238000003556 assay Methods 0.000 claims 1
- 210000000170 cell membrane Anatomy 0.000 claims 1
- 238000012258 culturing Methods 0.000 claims 1
- 239000012528 membrane Substances 0.000 claims 1
- 108020004999 messenger RNA Proteins 0.000 claims 1
- SRZQYTPACFNBMN-UHFFFAOYSA-N n-[5-[2-(2-methoxyanilino)-1,3-thiazol-4-yl]-4-methyl-1,3-thiazol-2-yl]benzamide;hydrobromide Chemical compound Br.COC1=CC=CC=C1NC1=NC(C2=C(N=C(NC(=O)C=3C=CC=CC=3)S2)C)=CS1 SRZQYTPACFNBMN-UHFFFAOYSA-N 0.000 claims 1
- 230000001766 physiological effect Effects 0.000 claims 1
- 102000004169 proteins and genes Human genes 0.000 claims 1
- 108090000623 proteins and genes Proteins 0.000 claims 1
- 150000003384 small molecules Chemical class 0.000 claims 1
- 239000000126 substance Substances 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US14931209P | 2009-02-02 | 2009-02-02 | |
| US61/149,312 | 2009-02-02 | ||
| PCT/US2010/022778 WO2010088630A2 (en) | 2009-02-02 | 2010-02-01 | Cell lines expressing cftr and methods of using them |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2012516686A JP2012516686A (ja) | 2012-07-26 |
| JP2012516686A5 true JP2012516686A5 (https=) | 2013-03-21 |
Family
ID=42396394
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011548377A Pending JP2012516686A (ja) | 2009-02-02 | 2010-02-01 | Ｃｆｔｒを発現する細胞株およびそれらを使用する方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US20120058918A1 (https=) |
| EP (1) | EP2393930A4 (https=) |
| JP (1) | JP2012516686A (https=) |
| CA (1) | CA2751215A1 (https=) |
| MX (1) | MX2011008131A (https=) |
| WO (1) | WO2010088630A2 (https=) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009094218A2 (en) * | 2008-01-22 | 2009-07-30 | Chromocell Corporation | Novel cell lines expressing nav and methods using them |
| US20100311610A1 (en) * | 2008-02-01 | 2010-12-09 | Chromocell Corporation | CELL LINES AND METHODS FOR MAKING AND USING THEM (As Amended) |
| US8945848B2 (en) | 2009-07-31 | 2015-02-03 | Chromocell Corporation | Methods and compositions for identifying and validating modulators of cell fate |
| US20120302573A1 (en) * | 2011-05-25 | 2012-11-29 | Paul Francis Jackson | Methods of inhibiting pro matrix metalloproteinase activation |
| US20130014288A1 (en) * | 2011-06-06 | 2013-01-10 | Carnegie Mellon University | Novel reporter-tagged recombinant membrane proteins with transmembrane linkers |
| FR2999191B1 (fr) * | 2012-12-12 | 2016-02-05 | Lesaffre & Cie | Souches probiotiques pour le traitement et/ou la prevention de la diarrhee |
| CA3023512A1 (en) * | 2016-05-09 | 2017-11-16 | Proteostasis Therapeutics, Inc. | Methods of identifying cftr modulators |
| WO2019060298A1 (en) | 2017-09-19 | 2019-03-28 | Neuroenhancement Lab, LLC | METHOD AND APPARATUS FOR NEURO-ACTIVATION |
| US11717686B2 (en) | 2017-12-04 | 2023-08-08 | Neuroenhancement Lab, LLC | Method and apparatus for neuroenhancement to facilitate learning and performance |
| US11478603B2 (en) | 2017-12-31 | 2022-10-25 | Neuroenhancement Lab, LLC | Method and apparatus for neuroenhancement to enhance emotional response |
| US12280219B2 (en) | 2017-12-31 | 2025-04-22 | NeuroLight, Inc. | Method and apparatus for neuroenhancement to enhance emotional response |
| US11364361B2 (en) | 2018-04-20 | 2022-06-21 | Neuroenhancement Lab, LLC | System and method for inducing sleep by transplanting mental states |
| US11452839B2 (en) | 2018-09-14 | 2022-09-27 | Neuroenhancement Lab, LLC | System and method of improving sleep |
| US11786694B2 (en) | 2019-05-24 | 2023-10-17 | NeuroLight, Inc. | Device, method, and app for facilitating sleep |
| CN111910008B (zh) * | 2020-08-21 | 2022-05-31 | 云南农业大学 | 一种鸡生长发育相关的分子标记及其应用 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20020164782A1 (en) * | 1999-02-10 | 2002-11-07 | Gregory Richard J. | Adenovirus vectors for gene therapy |
| WO2001003722A1 (en) * | 1999-07-09 | 2001-01-18 | Mayo Foundation For Medical Education And Research | Cftr polypeptides, fragments thereof and methods of use to overcome biosynthetic misprocessing |
| AU2003272248A1 (en) * | 2002-08-30 | 2004-03-19 | University Of Pittsburgh Of The Commonwealth System Of Higher Education | Polypeptides for increasing mutant cftr channel activity |
| AU2005251745A1 (en) * | 2004-06-04 | 2005-12-22 | The Regents Of The University Of California | Compounds having activity in increasing ion transport by mutant-CFTR and uses thereof |
| CA2600869A1 (en) * | 2005-03-18 | 2006-09-28 | The Regents Of The University Of California | Compounds having activity in correcting mutant-cftr processing and uses thereof |
| CN101198696B (zh) * | 2005-04-13 | 2014-02-26 | 阿斯利康(瑞典)有限公司 | 包含产生需要γ-羧化的蛋白质用的载体的宿主细胞 |
| KR20090019790A (ko) * | 2006-05-19 | 2009-02-25 | 더 스크립스 리서치 인스티튜트 | 단백질 미스폴딩의 치료 |
| AU2008233256B2 (en) * | 2007-03-28 | 2013-06-27 | The Curators Of The University Of Missouri | Transgenic animal models of disease |
-
2010
- 2010-02-01 MX MX2011008131A patent/MX2011008131A/es not_active Application Discontinuation
- 2010-02-01 CA CA2751215A patent/CA2751215A1/en not_active Abandoned
- 2010-02-01 US US13/147,327 patent/US20120058918A1/en not_active Abandoned
- 2010-02-01 WO PCT/US2010/022778 patent/WO2010088630A2/en not_active Ceased
- 2010-02-01 JP JP2011548377A patent/JP2012516686A/ja active Pending
- 2010-02-01 EP EP10736545A patent/EP2393930A4/en not_active Withdrawn
-
2014
- 2014-11-24 US US14/552,192 patent/US20150315554A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012516686A5 (https=) | ||
| Zhou et al. | Single-cell analysis reveals regulatory gene expression dynamics leading to lineage commitment in early T cell development | |
| Deutsch et al. | The impact of single-cell genomics on adipose tissue research | |
| Micheel et al. | Advances in non-coding RNA sequencing | |
| JP2016514950A (ja) | 標的細胞の選択的富化のための方法、組成物、キット、及びシステム | |
| CN103459611A (zh) | 对多能干细胞的效用和安全性进行表征的功能基因组学研究 | |
| KR20220118295A (ko) | 고 처리량 단일 세포 라이브러리, 및 이의 제조 방법 및 사용 방법 | |
| JP6143265B2 (ja) | 人工多能性幹細胞の選別方法 | |
| Guo et al. | Single-nucleus RNA-seq: open the era of great navigation for FFPE tissue | |
| JP2012514983A5 (https=) | ||
| Liu et al. | Advances in single-cell toxicogenomics in environmental toxicology | |
| Puzzi et al. | Knock down of plakophillin 2 dysregulates adhesion pathway through upregulation of miR200b and alters the mechanical properties in cardiac cells | |
| Hoffmann et al. | From the psychiatrist’s couch to induced pluripotent stem cells: bipolar disease in a dish | |
| Bekhite et al. | Human induced pluripotent stem cell as a disease modeling and drug development platform—a cardiac perspective | |
| Boheler et al. | Concise review: cell surface N-linked glycoproteins as potential stem cell markers and drug targets | |
| Gandhi et al. | Evolutionary patterns of non-coding RNA in cardiovascular biology | |
| Dong et al. | Serum‐free culture system for spontaneous human mesenchymal stem cell spheroid formation | |
| Budsuren et al. | MSTN regulatory network in Mongolian horse muscle satellite cells revealed with miRNA interference technologies | |
| Ge et al. | New insight into the role of the leucine aminopeptidase 3 (LAP3) in cell proliferation and myogenic differentiation in sheep embryonic myoblasts | |
| Nikitina et al. | Stem cell-based trophoblast models to unravel the genetic causes of human miscarriages | |
| WO2015086132A1 (en) | Assays and monitoring paradigms for stem cell culture | |
| He et al. | Genome‐wide location analysis by pull down of in vivo biotinylated transcription factors | |
| Gu et al. | Differential microRNA expression in porcine endometrium related to spontaneous embryo loss during early pregnancy | |
| Struijk et al. | ITGA6+ human testicular cell populations acquire a mesenchymal rather than germ cell transcriptional signature during long-term culture | |
| Little et al. | A Digital Microfluidic Platform for the Microscale Production of Functional Immune Cell Therapies |